Ποια είναι η τιμή για Purple Biotech Ltd. (PPBT)

Η τιμή για Purple Biotech Ltd. (PPBT) είναι $0.00323826

Ποια είναι η κεφαλαιοποίηση αγοράς για Purple Biotech Ltd. (PPBT)

Η κεφαλαιοποίηση αγοράς για Purple Biotech Ltd. (PPBT) είναι $104.81K

Purple Biotech Ltd. (PPBT) Τιμή και Κεφαλαιοποίηση Αγοράς

Purple Biotech Ltd., a clinical-stage company, is focused on creating therapies for cancer patients in the United States, specifically addressing challenges like tumor immune evasion and drug resistance. Its diverse oncology pipeline includes CM24, a humanized monoclonal antibody that targets and blocks carcinoembryonic antigen related cell adhesion molecule 1 (CEACAM1). Currently in Phase 2 clinical trials, CM24 is being investigated as a combination therapy with anti-PD-1 checkpoint inhibitors for treating pancreatic ductal adenocarcinoma. Another candidate is NT219, a small molecule compound in Phase 1/2 clinical trials, which functions by inhibiting insulin receptor substrate 1 and 2 (IRS1/2) and signal transducer and activator of transcription (STAT). This compound is being developed for recurrent and/or metastatic squamous cell carcinoma of the head and neck, or colorectal adenocarcinoma. Furthermore, IM1240, a multi-valent antibody designed to activate an anti-tumoral immune response against 5T4-positive tumors, is in its preclinical stage. The company has established significant collaborations, including an agreement with Bristol Myers Squibb Company for Phase 2 clinical trials to assess CM24 in combination with the PD-1 inhibitor nivolumab and chemotherapy, as well as a partnership with Mor Research Applications. Formerly known as Kitov Pharma Ltd., the company adopted the name Purple Biotech Ltd. in December 2020 and is headquartered in Rehovot, Israel.

Η τιμή για PPBT	Το περιουσιακό στοιχείο B	Η κεφαλαιοποίηση αγοράς του B	Αποτελέσματα
$168,876 $104.81K	NVDA	$5.466T	+5,215,023,849.19%
$137,731 $104.81K	AAPL	$4.458T	+4,253,248,315.50%
$128,998 $104.81K	GOOG	$4.175T	+3,983,544,228.68%
$113,349 $104.81K	MSFT	$3.669T	+3,500,297,589.27%
$88,162.17 $104.81K	AMZN	$2.853T	+2,722,513,793.08%

Η τιμή για PPBT

Το περιουσιακό στοιχείο B

Η κεφαλαιοποίηση αγοράς του B

Αποτελέσματα

$168,876 $104.81K